[ad_1] Generic drugmaker Dr. Reddy’s Laboratories has received establishment inspection report (EIR) for its Srikakulam formulations manufacturing facility from the U.S. Food and Drug Administration (U.S. FDA) with a voluntary action indicated (VAI) classification. Following a good manufacturing practice (GMP) and a pre-approval inspection (PAI) in July, the facility (FTO 11) received seven observations from […]
Continue Reading
[ad_1] According to Natco Pharma, during the April-June quarter this year, the business faced pricing pressure in the U.S. product portfolio and the company incurred increased R&D expenses on account of high value projects. File | Photo Credit: Reuters Generic drugmaker Natco Pharma reported consolidated net profit for the June quarter declined more than 28% […]
Continue Reading
[ad_1] Generic drugmaker and biotech company Laurus Labs reported consolidated net profit for June quarter surged to ₹163 crore from ₹13 crore year earlier. The higher net profit came on a 31% increase in revenue from operations to ₹1,570 crore (₹1,195 crore). Founder and CEO Satyanarayana Chava attributed the performance to increasing contributions from CDMO […]
Continue Reading